2024. Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL’HIV open-label, factorial randomised controlled trial. Swiss Medical Weekly. 154, 4 (Apr. 2024), 3762. DOI:https://doi.org/10.57187/s.3762.